Exicure Inc
XCUR7.600USD
+0.714+10.37%
종가 08/04, 16:00（ET）시세는 15분 지연됩니다
48.02M시가총액
손실P/E TTM
자세한 내용은 Exicure Inc 회사
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
회사 정보
종목 코드 XCUR
회사 이름Exicure Inc
상장일May 09, 2018
CEOMr. Paul Kang
직원 수7
유형Ordinary Share
회계 연도 종료May 09
주소2430 N. Halsted St.
도시CHICAGO
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호60614
전화18476731707
웹사이트https://www.exicuretx.com/
종목 코드 XCUR
상장일May 09, 2018
CEOMr. Paul Kang
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Chang Keun Choi
Mr. Chang Keun Choi
Director
Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Minwoo Kang
Mr. Minwoo Kang
Director
Director
--
--
Mr. Sangwook Song
Mr. Sangwook Song
Director
Director
--
--
Mr. Joshua (Josh) Miller
Mr. Joshua (Josh) Miller
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Company Secretary, Director
Chief Financial Officer, Company Secretary, Director
--
--
Mr. Ho (John) Jung
Mr. Ho (John) Jung
Director
Director
--
--
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Paul Kang
Mr. Paul Kang
Director
Director
--
--
Mr. Ho (John) Jung
Mr. Ho (John) Jung
Director
Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Chang Keun Choi
Mr. Chang Keun Choi
Director
Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Minwoo Kang
Mr. Minwoo Kang
Director
Director
--
--
Mr. Sangwook Song
Mr. Sangwook Song
Director
Director
--
--
Mr. Joshua (Josh) Miller
Mr. Joshua (Josh) Miller
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Company Secretary, Director
Chief Financial Officer, Company Secretary, Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Wed, Jul 16
마지막 업데이트: Wed, Jul 16
주주
주주 유형
주주
주주
비율
Hitron Systems Inc Employees
52.76%
DGP Co., Ltd.
7.80%
Sangsangin Investment & Securities Co. Ltd.
6.86%
Abingworth Management Limited
4.46%
CBI USA, Inc.
2.59%
Other
25.53%
주주
주주
비율
Hitron Systems Inc Employees
52.76%
DGP Co., Ltd.
7.80%
Sangsangin Investment & Securities Co. Ltd.
6.86%
Abingworth Management Limited
4.46%
CBI USA, Inc.
2.59%
Other
25.53%
주주 유형
주주
비율
Corporation
63.15%
Research Firm
6.87%
Venture Capital
4.46%
Investment Advisor/Hedge Fund
0.61%
Endowment Fund
0.17%
Hedge Fund
0.02%
Investment Advisor
0.01%
Other
24.72%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
39
5.19M
82.14%
+466.24K
2025Q1
39
5.11M
80.94%
+626.75K
2024Q4
39
2.19M
79.53%
+1.26M
2024Q3
38
1.16M
47.48%
+231.16K
2024Q2
41
935.92K
56.32%
-7.21K
2024Q1
63
954.65K
57.41%
-102.69K
2023Q4
69
1.01M
60.85%
-61.54K
2023Q3
83
1.06M
66.48%
-70.11K
2023Q2
96
1.06M
66.44%
-83.25K
2023Q1
130
1.14M
110.73%
-98.99K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Hitron Systems Inc Employees
3.33M
52.76%
--
--
Mar 12, 2025
DGP Co., Ltd.
849.22K
13.44%
+237.22K
+38.76%
Sep 12, 2024
Abingworth Management Limited
281.64K
4.46%
--
--
Mar 31, 2025
CBI USA, Inc.
163.66K
2.59%
--
--
Sep 12, 2024
Geode Capital Management, L.L.C.
19.10K
0.3%
+6.45K
+51.03%
Mar 31, 2025
The Vanguard Group, Inc.
19.03K
0.3%
+19.03K
--
Mar 31, 2025
Northwestern University
10.43K
0.17%
--
--
Mar 31, 2025
Tower Research Capital LLC
1.16K
0.02%
+452.00
+63.93%
Mar 31, 2025
UBS Financial Services, Inc.
566.00
0.01%
-1.07K
-65.49%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
비율0%
iShares Micro-Cap ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Aug 26, 2024
Merger
5<1
Aug 26, 2024
Merger
5<1
Aug 26, 2024
Merger
5<1
Aug 26, 2024
Merger
5<1
Jun 29, 2022
Merger
30<1
Jun 29, 2022
Merger
30<1
날짜
유형
비율
Aug 26, 2024
Merger
5<1
Aug 26, 2024
Merger
5<1
Aug 26, 2024
Merger
5<1
Aug 26, 2024
Merger
5<1
Jun 29, 2022
Merger
30<1
Jun 29, 2022
Merger
30<1
Jun 29, 2022
Merger
30<1
Jun 29, 2022
Merger
30<1
